|
Characteristics of the population 65 years and older with a fragility fracture by gender |
|||
| Women |
Men |
p-value |
|
|
|
|||
| Population 65 years in 2000 |
554,154 |
387,062 |
- |
| Number of fragility fractures (per 1000) |
19,813 (36 ‰) |
6039 (16 ‰) |
< 0.0001 |
| Average age in years (standard deviation) |
78.7 (7.7) |
76.6 (7.6) |
< 0.0001 |
| Age category in years (%) |
< 0.0001 |
||
| 65–69 |
2842 (14.3) |
1289 (21.3) |
|
| 70–74 |
3581 (18.1) |
1326 (22.0) |
|
| 75–79 |
4312 (21.8) |
1333 (22.1) |
|
| ≥80 |
9078 (45.8) |
2091 (34.6) |
|
| Site of fragility fracture (%) |
< 0.0001 |
||
| Vertebral |
3006 (15.2) |
1200 (19.9) |
|
| Wrist |
3391 (17.1) |
734 (12.2) |
|
| Hip |
9194 (46.4) |
2961 (49.0) |
|
| Humerus |
4222 (21.3) |
1144 (18.9) |
|
| Social status* (%) |
< 0.0001 |
||
| Living in a LTCF |
1303 (6.6) |
352 (5.8) |
|
| Living at home with maximum IS |
1840 (9.3) |
234 (3.9) |
|
| Living at home with partial IS |
8757 (44.2) |
2142 (35.5) |
|
| Living at home with no IS |
7913 (39.9) |
3311 (54.8) |
|
| Comorbidity index – mean (quartiles) |
7.2 (3, 6, 10) |
6.9 (2, 6, 10) |
0.0065 |
| Prior BMD testing (%) |
1572 (7.9) |
100 (1.7) |
< 0.0001 |
| Prior OP treatment (%) |
3954 (20.0) |
247 (4.1) |
< 0.0001 |
| Long-term glucocorticoid use (%) |
407 (2.0) |
132 (2.2) |
0.5310 |
| Average distance to nearest BMD device |
20.3 km |
23.4 km |
< 0.0001 |
| Median distance to nearest BMD device |
3.0 km |
3.5 km |
< 0.0001 |
| BMD testing 2 years after fracture (%) |
2594 (13.1) |
281 (4.6) |
< 0.0001 |
| OP treatment one year after fracture (%) |
5889 (29.7) |
596 (9.9) |
< 0.0001 |
| Death 2 years after fracture (%) |
4507 (22.8) |
2112 (35.0) |
< 0.0001 |
|
* LTCF: Long-term care facility; IS: income supplement | |||
Vanasse et al. BMC Musculoskeletal Disorders 2005 6:33 doi:10.1186/1471-2474-6-33 |
|||